Blog GLP-1 Injections: The Practical Guide to Administration, Storage, and Access GLP-1 injections are weekly subcutaneous medications most commonly semaglutide or tirzepatide used for weight management and blood sugar control
Retatrutide is a novel polypeptide being investigated for its multi-agonist properties, targeting the GLP-1, GIP, and glucagon receptors
Common physical changes patients describe after GLP-1-supported weight loss include: Looser skin around the abdomen, flanks, and lower back Sagging or bat wing tissue along the upper arms Thigh skin that appears crepey or hangs when sitting or standing Decreased fullness in the breasts or buttocks Less volume in the face, particularly the cheeks and under the eyes These changes can feel surprising
& Brown, J
Presented for research literature review only Maher CB et al
Meet with one of our experienced Nurse Practitioners one-on-one (phone call or video call) - we will review your medical history, discuss your goals, answer any questions you have, and suggest a personalized weight loss plan made just for you, including side effect mitigation support